Hematology TimesProblems in pediatric cancer care in EuropeSeptember 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Hematology NewsData support subcutaneous bortezomib in multiple myelomaSeptember 29, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesPregnant cancer patients: Start treatment ASAPSeptember 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesVariations in blood cancer survival across EuropeSeptember 28, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesNICE backs discounted idelalisib for CLLSeptember 27, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesChildhood cancer increases material hardshipSeptember 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Hematology TimesReducing side effects of CAR T-cell therapySeptember 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsTopical resiquimod effective for early-stage cutaneous T-cell lymphomaSeptember 24, 2015T Cell LymphomasMelanomaLymphoma & Plasma Cell Disorders
The Journal of Community and Supportive OncologyHospital readmission following transplantation: identifying risk factors and designing preventive measuresSeptember 23, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeImmunotherapy: Inject locally, treat globally?September 23, 2015Lymphoma & Plasma Cell DisordersT Cell Lymphomas
Hematology TimesInsights from the 5-year follow-up of CTL019 in CLLSeptember 23, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesFirst-line BV can produce high response rate in older HL patientsSeptember 22, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesCDK inhibitor active against lymphoma tooSeptember 22, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
Hematology TimesmAb gets priority review as maintenance in CLLSeptember 22, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Oncology PracticeHELIOS trial: Ibrutinib safely boosts survival in CLL/SLLSeptember 21, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersCLL
